Does Medicare Cover Ozempic, Zepbound and Other GLP-1 Inhibitors?
GLP-1 drugs, such as Ozempic, are reshaping diabetes care and weight loss. Find out if Medicare covers them and if they’re right for you.
Innovent brings a new mechanism to obesity market with China approval
Innovent said on Friday that its obesity medicine mazdutide has been approved in China, becoming the first dual GLP-1/glucagon agonist to be greenlit for the disease anywhere in the world. …
GLP-1s linked to cases of illness and death
GLP-1 drugs, which have seen widespread success, have been linked to a number of cases of pancreatitis in the UK, which have led to hospitalisations and even deaths.
STAT+: Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We expect to manicure the Pharmalot grounds, hang with a short person or two, and catch up on […]
New Ozempic alternative only needs to be taken once a month and leads to ‘substantial weight loss’
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials. Drugs like Wegovy and Mounjaro – or diabetes jab Ozempic – need to be injected once weekly to see results. PAA new weight loss jab currently being trialled only needs to be given […]
Why Shares in Amylyx Pharmaceuticals Soared This Week
Shares in Amylyx Pharmaceuticals (NASDAQ: AMLX) were up almost 28% in the week to Friday morning. The move comes after an analyst at Guggenheim initiated coverage of the small-cap stock and issued a buy recommendation, accompanied by a price target of $17. For reference, the stock price at the time of writing is $6.50. The […]
Why Shares in Amylyx Pharmaceuticals Soared This Week
Shares in Amylyx Pharmaceuticals (NASDAQ: AMLX) were up almost 28% in the week to Friday morning. The move comes after an analyst at Guggenheim initiated coverage of the small-cap stock and issued a buy recommendation, accompanied by a price target of $17. For reference, the stock price at the time of writing is $6.50. Why […]
Novo Nordisk’s Pricing Crossroads: Regulatory Risks and Competitive Pressures Threaten GLP-1 Dominance – AInvest
Novo Nordisk’s Pricing Crossroads: Regulatory Risks and Competitive Pressures Threaten GLP-1 Dominance AInvest
I’ve gone from a size 20 to an 8 & lost 8 stone on Mounjaro – I’ve had hair loss but don’t mind, I like my locks thinner
A WOMAN has revealed that thanks to Mounjaro, she has lost eight stone and has dropped from a size 20 to an 8. But Alexandra, 33, who is from the UK and is currently living in Dubai, expressed that since using weight-loss jabs, she has suffered with hair loss. tiktok/@alexandraindubaiA young woman has revealed that […]
Diabetes Drug Tied to Decreased Dementia Risk in T2D
Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests. Medscape Medical News